These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15274680)

  • 41. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
    Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
    J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct hemoperfusion using polymyxin-B immobilized fiber for severe septic patients with hematological disorders: a single-center analysis.
    Mori M; Onaka T; Yonezawa A; Kitagawa T; Sasaki Y; Imada K
    J Infect Chemother; 2014 Apr; 20(4):282-4. PubMed ID: 24485325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymyxin B-immobilized fiber column direct hemoperfusion and continuous hemodiafiltration in premature neonates with systemic inflammatory response syndrome.
    Maede Y; Ibara S; Tokuhisa T; Ishihara C; Hirakawa E; Matsui T; Takahashi D; Machigashira S; Minakami H
    Pediatr Int; 2016 Nov; 58(11):1176-1182. PubMed ID: 27062100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood purification for critical illness: cytokines adsorption therapy.
    Tsuchida K; Yoshimura R; Nakatani T; Takemoto Y
    Ther Apher Dial; 2006 Feb; 10(1):25-31. PubMed ID: 16556133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience.
    Sato T; Shoji H; Koga N
    Ther Apher Dial; 2003 Apr; 7(2):252-8. PubMed ID: 12918952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemoperfusion with an immobilized polymyxin B fiber column improves tissue oxygen metabolism.
    Kushi H; Miki T; Nakahara J; Okamoto K; Kawahara Y; Saito T; Tanjoh K
    Ther Apher Dial; 2006 Oct; 10(5):430-5. PubMed ID: 17096698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymyxin B hemoperfusion prevents acute kidney injury in sepsis model.
    Mitaka C; Masuda T; Kido K; Uchida T; Abe S; Miyasho T; Tomita M; Inada E
    J Surg Res; 2016 Mar; 201(1):59-68. PubMed ID: 26850185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endotoxin and Cytokine Sequential Hemoadsorption in Septic Shock and Multi-Organ Failure.
    Ruiz-Rodríguez JC; Chiscano-Camón L; Palmada C; Ruiz-Sanmartin A; Pérez-Carrasco M; Larrosa N; González JJ; Hernández-González M; Ferrer R
    Blood Purif; 2022; 51(7):630-633. PubMed ID: 34515070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental study of extracorporeal perfusion for septic shock.
    Sato T; Orlowski JP; Zborowski M
    ASAIO J; 1993; 39(3):M790-3. PubMed ID: 8268646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of polymyxin-B-based hemoperfusion in kidney and liver transplant recipients.
    Novelli G; Morabito V; Ferretti G; Poli L; Novelli S; Ruberto F; Pugliese F; Mennini G; Rossi M; Berloco PB
    Transplant Proc; 2012 Sep; 44(7):1966-72. PubMed ID: 22974884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct hemoperfusion using polymyxin-B immobilized fiber for septic shock after cardiac surgery.
    Murakami M; Miyauchi Y; Nishida M; Okada H; Hamano K
    Circ J; 2009 Apr; 73(4):658-61. PubMed ID: 19246811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of a new extracorporeal system using CTR on mortality and inflammatory responses to bacterial toxin-induced multiple organ dysfunction syndrome in rabbits.
    Kawatsu M; Wada J; Kitano M; Ogino E; Sakurai H; Furuyoshi S; Tani N
    Blood Purif; 2006; 24(3):327-34. PubMed ID: 16534195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Endotoxin removal in septic shock].
    Matsuda K; Hirasawa H; Oda S; Shiga H; Nakanishi K; Nakamura M
    Nihon Geka Gakkai Zasshi; 2002 Dec; 103(12):880-6. PubMed ID: 12599928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early initiation of polymyxin B-immobilized fiber therapy effective for septic shock after aortic replacement.
    Murakami M; Miyauchi Y; Nishida M; Okada H; Hamano K
    Ann Thorac Cardiovasc Surg; 2007 Aug; 13(4):287-9. PubMed ID: 17717510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients.
    Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yokota H
    Indian J Crit Care Med; 2010 Jan; 14(1):35-9. PubMed ID: 20606907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early recovery in hemodynamics after direct hemoperfusion with polymyxin B-immobilized fibers may predict mortality rate in patients with septic shock.
    Kobayashi A; Iwasaki Y; Kimura Y; Kawagoe Y; Ujike Y
    J Anesth; 2010 Oct; 24(5):709-15. PubMed ID: 20640454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic effect of direct hemoperfusion with a polymyxin B-immobilized fiber column in the treatment of HIV-negative severe pneumocystis pneumonia.
    Tachikawa R; Tomii K; Murase K; Ueda H; Harada Y; Kida Y; Ishihara K
    Respiration; 2011; 81(4):318-24. PubMed ID: 20530959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of polymyxin B-immobilized fiber using a rat cecal ligation and perforation model.
    Ito M; Kase H; Shimoyama O; Takahashi T
    ASAIO J; 2009; 55(3):246-50. PubMed ID: 19357500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion.
    Sekino M; Murakami Y; Sato S; Shintani R; Kaneko S; Iwasaki N; Araki H; Ichinomiya T; Higashijima U; Hara T
    Sci Rep; 2023 May; 13(1):7295. PubMed ID: 37147345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemoperfusion with an immobilized polymyxin B fiber column decreases macrophage and monocyte activity.
    Kushi H; Miki T; Sakagami Y; Sato J; Saito T; Tanjoh K
    Ther Apher Dial; 2009 Dec; 13(6):515-9. PubMed ID: 19954475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.